XBI241206C112000
- 0.20
- 0.000.00%
SPDR S&P Biotech ETF Newsroom
FDA-Approved Sickle Cell Therapies From Bluebird Bio And Vertex Join Medicaid Innovation Program
CMS Rolls Out New Payment Model for Vertex, Bluebird Gene Therapies
10 Health Care Stocks Whale Activity In Today's Session
S&P and Nasdaq on Track for Third Record Close This Week | Live Stock
Incyte Gains Amid Takeover Speculation
Fresh Closing Highs from S&P 500 and Nasdaq | Wall Street Today
Looking At Gilead Sciences's Recent Unusual Options Activity
How Is The Market Feeling About Insmed?
Top Quant-rated Cyclical Stocks, as Group Is Expected to Outperform in 2025
Tuesday S&P 500 Pulls Back From Highs, Nasdaq Climbs | Live Stock
Screening For Black Friday Bargains In The Stock Market
S&P 500 and Nasdaq Hit Closing and Trading Highs Monday | Wall Street Today
Gilead Sciences Ticks Upward for the Eight Consecutive Session
Looking Into Natera's Recent Short Interest
Big Pharma Pushes To Revise Biden-era Medicare Drug Price Negotiation Law Under Trump
December Starts With a Mixed Market | Live Stock
Archer Aviation, Hims & Hers Health And Urban Outfitters Are Among Top 8 Mid-Cap Gainers Last Week (Nov 25-Nov 29): Are The Others In Your Portfolio?
Trending Stocks This Week as Holiday Season Begins With Thanksgiving Break
Stocks Ride to Best Month in a Year as 'Red Sweep' Unleashes 'Animal Spirits'
Barclays's 'Bang-for-the-buck' Tail Hedging ETFs: HYG, XLF, IYR